WebNursing Implications Assessment & Drug Effects Obtain history of hypersensitivity to penicillins, cephalosporins, or other drugs prior to administration. Lab tests: C&S prior to first dose of the drug; start drug pending results. (Hct … WebLab Test Considerations: Monitor potassium concentrations during therapy; may cause hypokalemia. Monitor electrolytes, BUN, creatinine, and prothrombin time weekly during prolonged therapy. Toxicity and Overdose: If overdose occurs, reduction or discontinuation of therapy is the only treatment necessary because of the short duration of dobutamine.
Cisplatin Flashcards Quizlet
WebJoin NURSING.com to watch the full lesson now. Start Trial. Try NURSING.com Risk Free for 3 Days. Clear, Concise, Visual Nursing School Supplement. 6,500+ Practice NCLEX … http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/C085.html dark spot on labia
5.14 Xanthine Derivatives – Nursing Pharmacology - BCcampus
Established combination therapy (cisplatin, vinblastine, bleomycin) in patient with metastatic testicular tumors and with doxorubicin for metastatic ovarian tumors following appropriate surgical or radiation therapy. See more A heavy metal complex with platinum as central atom surrounded by 2 chloride atoms and 2 ammonia molecules in the cis chemical position. … See more Cell cycle-nonspecific, i.e., effective throughout the entire cell life cycle. Carcinogenicity has not been fully studied, but other compounds with similar action mechanisms and mutogenicity have been studied. See more History of hypersensitivity to cisplatin or other platinum-containing compounds; impaired renal function; myelosuppression; impaired hearing; history of gout and urate renal stones; hypomagnesia; … See more WebAntineoplastic Drugs Nursing Considerations & Management Practice Exam Antineoplastic agents comprise one aspect of chemotherapy. These drugs act on and kill altered human cells. While their action is intended … WebCi Absolute contraindications hearing impairment, allergic rxn to cisplatin or other platinum containing compounds Ci Dosing metastatic ovarian tumor- single agent, 100 mg/m (2)/cycle IV every 4 weeks, combination therapy, 75 to 100 mg/m (2)/cycle IV every 4 weeks (day 1) administered sequentially with Ci Common side effects dark spot on leg that won\u0027t go away